Picture of Deltex Medical logo

DEMG Deltex Medical Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Deltex Medical, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.34-0.21-0.794-0.978-1.15
Depreciation
Amortisation
Non-Cash Items0.2530.2550.3080.2660.359
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.6520.3310.2750.3070.053
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-1.320.609-0.068-0.291-0.606
Capital Expenditures-0.232-0.26-0.171-0.644-0.744
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.0180.0590
Other Investing Cash Flow
Cash from Investing Activities-0.214-0.201-0.171-0.644-0.744
Financing Cash Flow Items-0.1320-0.0030.50.135
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.88-0.0670.190.5021.41
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.3610.328-0.055-0.440.058